You would have to ask them Maldowl.
Of greater relevance is this article which came inteview last July. Authors include Charlie Birse, Harvey Pass and many more.
Blood-based lung cancer biomarkers identified through proteomic discovery in cancer tissues, cell lines and conditioned medium.
This article flags the prospect that there may be signs of life associated with the Celera assay. We can but wait and see but the paper does include the following key observation:
" An 8-marker model was developed (TFPI, MDK, OPN, MMP2, TIMP1, CEA, CYFRA 21–1, SCC) which accurately distinguished subjects with lung cancer (n = 50) from high risk smokers (n = 50) in an independent validation study (AUC = 0.775). "
cheers
- Forums
- ASX - By Stock
- AN1
- Ann: Fourth Midkine Symposium to be held in Budapest-CDY.AX
Ann: Fourth Midkine Symposium to be held in Budapest-CDY.AX, page-77
Featured News
Add AN1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
0.8¢ |
Change
0.000(0.00%) |
Mkt cap ! $3.690M |
Open | High | Low | Value | Volume |
0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Featured News
AN1 (ASX) Chart |
Day chart unavailable